2021 annual financial data
Oncolytics Biotech 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -20,925,470 CAD and net income was -20,980,772 CAD.
Operating cash flow was -22,434,009 CAD.
Get free Oncolytics Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -20,925,470 CAD
- Net income
- -20,980,772 CAD
- Operating cash flow
- -22,434,009 CAD